Form 8-K - Current report:
SEC Accession No. 0001140361-25-015301
Filing Date
2025-04-24
Accepted
2025-04-24 07:00:41
Documents
15
Period of Report
2025-04-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20047730_8k.htm   iXBRL 8-K 29963
2 EXHIBIT 99.1 ef20047730_ex99-1.htm EX-99.1 12694
6 image001.jpg GRAPHIC 2614
  Complete submission text file 0001140361-25-015301.txt   186072

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insm-20250424.xsd EX-101.SCH 3976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20250424_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20250424_pre.xml EX-101.PRE 16040
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20047730_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 25863536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)